PN Newsome, ME Allison, PA Andrews, G Auzinger, CP Day, JW Ferguson, PA Henriksen, SG Hubscher, H Manley, PJ McKiernan, C Millson, D Mirza, JM Neuberger, J Oben, S Pollard, KJ Simpson, D Thorburn, JW Tomlinson, JS Wyatt
[ Gut 2012;61:484e500. doi:10.1136/gutjnl-2011-300886 ]
Non-alcoholic steatohepatitis (NASH) is an increasing cause of liver disease necessitating liver transplantation. In patients with advanced NASH, there are often coexistent clinical issues that impact on the outcome of liver transplantation. There are no guidelines for the assessment and management of patients with NASH undergoing liver transplantation. A group was therefore invited by the Council of the British Transplant Society (BTS) to prepare guidelines for the management of NASH before and after liver transplantation. The guideline is approved by the British Society of Gastroenterology, the British Association for the Study of Liver and NHS Blood and Transplant.